[Announcement]
COVID-19 Antibody Test Available with our RHM Advisors
RHM COVID-19 Test
Antibodies have been found to be a highly sensitive biomarkers in infectious disease diagnosis, previous studies on SARS, MERS and more recently the ones on SARS-CoV2 have shown IgM antibodies to appear about the 3rd day from infection and IgG antibodies appear after 8 days. Profiling an individual’s antibody response is the only way to determine infections with few or no symptoms. Vibrant COVID-19 Ab assay is an in-vitro diagnostic test intended for the qualitative detection of IgG, IgA and IgM antibodies to SARS-CoV-2 in human serum collected from individuals who are suspected of COVID-19
Regulatory Statement
The US-based labs that RHM contracts with are certified under the Clinical Laboratory Improvements Amendment of 1988 (CLIA ’88), accredited by the College of American Pathologists (CAP), and has over 5 years’ experience designing, validating, and performing Laboratory Developed Tests (LDTs) for physicians and patients. Maintaining accreditation through the CAP requires that LDTs are validated to standards exceeding those listed in CLIA ’88 which defines the minimum standards that must be met in order to perform LDTs for diagnostic purposes.
Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. Not for the screening of donated blood.
Why Regenerative Health Management
Background & Approach
The power of Regenerative Medicine
The Future
is Now
Through advancing technologies, knowledge, and understanding, brilliant scientists and physicians continue to show the scientific and medical communities that regenerative medicine therapies and treatments can repair, rejuvenate, and even regenerate tissue that has been damaged by injury, disease or the natural aging process.
The practice of regenerative medicine capitalizes on the body’s own ability to heal itself. While regenerative therapies and treatments will not completely eliminate the need for pharmaceuticals and surgery, it does offer a seismic shift in treatment options and opportunities for patients.
Regenerative Health Management
The active on-going process of helping you navigate the complexities of Regenerative Medicine
The RHM Approach
Clarity
Clarity
Choice
Choice
Confidence
Confidence
Regenerative Health Management Process





We believe that successful outcomes for patients (and possibly regenerative medicine as a whole) will be directly correlated with physicians and patients managing behaviors and expectations together, through a relationship, that uses innovative treatments, therapies, and procedures as tools.
That is why 4 of the 5 steps in the RHM deal with time with, and advice from, a physician. The RHM physician can provide treatments, but it’s only a fraction of the way we understand the process of regenerative medicine.
Treatment process
RHM Physicians focus on 3 main areas
- Minimize Inflammation
- Balance Hormones
- Regenerative Therapies
Because of this, we developed a first of its kind
“Medical Advisory Program”
This RHM Program finds the economic incentives that help patients and physicians come together and give each what they need.
We Will Help You Every Step Of The Way
Tell us about your situation, and we’ll get in touch with you within 24 hours.